The partnership will help us to raise the profile of our cause to new audiences, who share our vision of health, inclusion and innovation for people affected by leprosy and lymphatic filariasis (LF).
"We are incredibly excited to be working with AMG over the next three years. It will give us an incredible opportunity to raise the profile of our cause to new audiences, who share our vision of health, inclusion and innovation for people affected by leprosy and LF."
Jimmy Innes, Lepra CEO
Find out more about corporate partnership opportunities with Lepra.